Will RFK Jr.’s push for psychedelics help or hurt the emerging field?
Veterans groups are among those seeking to access the drug ibogaine and other psychedelics to treat PTSD, opioid addiction and other conditions.
By Matthew Perrone
Latest ""
FDA rejects psychedelic MDMA as treatment for PTSD
MDMA research has been widely publicized by combat veterans, who say limited PTSD treatment options have contributed to higher military suicide rates.
By Matthew Perrone
DoD, FDA partner to speed up approval of freeze-dried plasma for use on the battlefield
The FDA is hoping to have a licensed product by the end of 2018.
By Charlsy Panzino